Continuous intelligence for the vessels that feed the brain.

NeuroSense™ continuous neurovascular monitoring

A conformal wearable that monitors cerebral blood flow continuously, with no cart, no cable, and no operator. Developed first for warfighter casualty care, with a path to civilian stroke and stenosis surveillance.

NoiseShield

NoiseShield is a research program addressing impact noise in multifamily buildings. It treats the building itself as the measurement surface, producing an objective, timestamped record of disturbance events without access to or modification of the unit above.

Continuous Neurovascular Intelligence

Lumorix is building the first platform that turns cerebral blood flow into a continuous signal. Today the vessels feeding the brain are examined only in episodes, inside a hospital, with a console and a trained sonographer. Between those episodes there is nothing. NeuroSense™ closes that gap. It is a conformal wearable that monitors cerebral blood flow continuously, with no cart, no cable, and no operator.

Doing this well is hard for reasons that have kept it out of a wearable until now. A body worn Doppler sensor has to pull a clean flow signal from deep vessels, through motion and tissue clutter, at a fraction of the power and size of a clinical system. Most attempts fail. Our approach is engineered to succeed where they fail, and the way we get there is deliberately not described on this site.

Validated where it counts

The platform is being developed with the Stanford Nanofabrication Facility as our fabrication and characterization partner. The platform's clinical direction is guided by our clinical advisor, Dr. Reza Bavarsad Shahripour, a board certified vascular neurologist and ASN certified neurosonologist at UC San Diego Health. Our scientific advisor for device and bioelectronics is Dr. Arash Takshi, a full professor of electrical engineering at the University of South Florida. The core architecture is patent pending, and warfighter casualty care is our lead application, pursued on a non dilutive government funding path.

Where the detail lives

Prior to patent publication, mechanism level detail stays off the public site by design. Performance targets, the analysis behind them, the full architecture, and the supporting data are shared with serious partners under NDA.

Warfighter casualty care

Developed first for warfighter traumatic brain injury and casualty care, on a non dilutive government funding path. The specifics of that pursuit are shared with qualified partners under NDA.

Civilian stroke and stenosis surveillance

The same platform extends to civilian stroke and stenosis surveillance, where episodic imaging leaves the same gap at far larger scale.

Credentials stated plainly.

Why now, and what capital unlocks.

Lumorix is at a fundable inflection point. The core architecture is patent pending and validated at the component level, the fabrication and clinical relationships are in place, and non dilutive government funding is in play. What capital unlocks now is the step from validated components to a working prototype.

Core architecture patent pending, with filings underway. Pre clearance.

Clinical and scientific advisors in vascular neurology and flexible bioelectronics.

The fabrication, integration, and benchtop validation that turn today's component results into a working prototype, the milestone that opens the path to the next generation platform and to clinical translation.